World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Prof
Charité - Universitätsmedizin, Berlin; Center for Advanced Neuroimaging; Bernstein Center for Computational Neuroscience
Showing your local timezone
Schedule
Sunday, November 21, 2021
3:00 PM Europe/Berlin
Seminar location
No geocoded details are available for this content yet.
Format
Past Seminar
Recording
Not available
Host
Ad hoc
Seminar location
No geocoded details are available for this content yet.
Every thought is associated with a unique pattern of brain activity. Thus, in principle, it should be possible to use these activity patterns as "brain fingerprints" for different thoughts and to read out what a person is thinking based on their brain activity alone. Indeed, using machine learning considerable progress has been made in such "brainreading" in recent years. It is now possible to decode which image a person is viewing, which film sequence they are watching, which emotional state they are in or which intentions they hold in mind. This talk will provide an overview of the current state of the art in brain reading. It will also highlight the main challenges and limitations of this research field. For example, mathematical models are needed to cope with the high dimensionality of potential mental states. Furthermore, the ethical concerns raised by (often premature) commercial applications of brain reading will also be discussed.
John-Dylan Haynes
Prof
Charité - Universitätsmedizin, Berlin; Center for Advanced Neuroimaging; Bernstein Center for Computational Neuroscience
Contact & Resources
neuro
neuro
The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss t
neuro
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzhe